I have asked myself a similar question but I don't know enough about the torso scanner development and came to the following conclusion.
- The brain scanner is just way too expensive for COVID-19. A blood test is cheaper, and easier to read.
- The Torso scanner - The Torso scanner is probably too early in its development phase. X-rays, nuclei tests kits, blood tests are far cheaper and easier to use and train people with.
- The brain scanner could help with this in analysing tissue changes. However there isn't enough medical knowledge to understand if there is any effect on the brain.
re: your point about adapting it to the chest - well....R&D lead time far too long and there are better ways/equipment to detect this. Hence this is why I think EMV is such a valuable stock - technical complexity and long lead times prevent new competitors.
Right way of thinking, probably the wrong product to use for this scenario.
I have asked myself a similar question but I don't know enough...
-
- There are more pages in this discussion • 2,711 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.02 |
Change
0.010(0.50%) |
Mkt cap ! $172.5M | |||
| Open | High | Low | Value | Volume |
| $2.02 | $2.02 | $2.00 | $28.54K | 14.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $1.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.02 | 13617 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| EMV (ASX) Chart |